Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket

Shares of Beyond Air, Inc. (NASDAQ:XAIR) fell sharply in today's pre-market trading after the company posted mixed fourth-quarter results.

Beyond Air reported quarterly losses of nine cents per share, which beat the analyst consensus estimate of a loss of 12 cents. Quarterly revenue came in at $1.15 million, which missed the Street estimate of $1.39 million and is up from revenue of $470,000 from the same period last year

Beyond Air shares dipped 23.5% to $0.2179 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

• PTL Limited (NASDAQ:PTLE) surged 148% to $0.4923 in pre-market trading after gaining 10% on Tuesday.
• XCF Global, Inc.  (NASDAQ:SAFX) shares jumped 67.6% to $2.85 in pre-market trading after dipping 23% on Tuesday.
• Leishen Energy Holding Co., Ltd. (NASDAQ:LSE) jumped 53.5% to $8.52 in pre-market trading after tumbling 17% on Tuesday.
• Gulf Resources, Inc. (NASDAQ:GURE) gained 44.2% to $0.8652 in pre-market trading after gaining 5% on Tuesday.
• Mesa Royalty Trust (NYSE:MTR) rose 33.7% to $8.76 in pre-market trading after gaining 10% on Tuesday.
• GeoVax Labs, Inc. (NASDAQ:GOVX) rose 30% to $1.17 in pre-market trading. GeoVax Labs shares dipped 32% on Tuesday after the company in a filing disclosed it will sell 6.15 million common units.
• Helius Medical Technologies, Inc. (NASDAQ:HSDT) climbed 26.9% to $0.3921 in pre-market trading after dipping 18% on Tuesday.
• TMC the metals company Inc. (NASDAQ:TMC) surged 11.8% to $6.07 in pre-market trading. Korea Zinc recently announced an equity investment of $85.2 million in the company.
• Liminatus Pharma, Inc. (NASDAQ:LIMN) gained 7.7% to $13.82 in pre-market trading after surging over 5% on Tuesday.
• BiomX Inc. (NYSE:PHGE) fell 7.7% to $0.4200 in pre-market trading.

Losers

• Catalyst Biosciences, Inc. (NASDAQ:CBIO) shares tumbled 59.4% to $5.39 in pre-market trading. Crescent Biopharma recently completed closing of merger with GlycoMimetics and previously announced private placement of $200 million.
• Biomea Fusion, Inc. (NASDAQ:BMEA) shares fell 26.2% to $2.14 in pre-market trading after the company announced the pricing of public offering of securities.
• BP Prudhoe Bay Royalty Trust (NYSE:BPT) dipped 24.2% to $0.54 in pre-market trading. BP Prudhoe Bay Royalty Trust announced commencement of trust asset sale process.
• Eyenovia, Inc. (NASDAQ:EYEN) declined 22.4% to $5.41 in pre-market trading. Eyenovia shares jumped 135% on Tuesday after the company announced it entered into a securities purchase agreement for a $50 million private placement in public equity with institutional accredited investors.
• CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) dipped 22.4% to $15.35 in pre-market trading. CERo Therapeutics shares jumped 189% on Tuesday after the company received U.S. Food and Drug Administration (FDA) Orphan Drug Designation for CER-1236.
• Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) declined 21% to $0.6485 in pre-market trading after the company announced exercise of warrants for $2.67 million gross proceeds.
• LeddarTech Holdings Inc. (NASDAQ:LDTC) fell 14.4% to $0.1624 in pre-market trading. LeddarTech recently announced intention to file under the Bankruptcy and Insolvency Act in Canada.
• Regencell Bioscience Holdings Limited (NASDAQ:RGC) fell 14.1% to $66.98 in pre-market trading after gaining 30% on Tuesday.
• Vince Holding Corp. (NYSE:VNCE) fell 13.4% to $1.28 in pre-market trading after dipping 12% on Tuesday. Vince Holding recently posted a first-quarter loss of 37 cents per share.

Now Read This:

• Top 3 Health Care Stocks That Are Ticking Portfolio Bombs

Photo via Shutterstock